 BioNTech, the biotech company known for its role in developing a COVID-19 vaccine, has agreed to acquire UK-based artificial intelligence AI start-up InstaDeep for 562 million. The deal, the German groups biggest yet, comes after a multi-year collaboration with InstaDeep, which led to the development of an early warning system to predict future variants of the SARS-CoV-2 virus. 